Companion Dog Walking for ICU Survivor Health

NCT05820308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-05-10

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the feasibility and acceptability of a randomized controlled trial comparing a pet dog walking intervention to an attention control education intervention in adult intensive care unit survivors.

The main question\[s\] it aims to answer are:

* What is the feasibility of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors.
* What is the acceptability of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors.

The secondary question\[s\] it aims to answer are:

\- What are the differences in depression, anxiety, serum cortisol, and quality of life between and within a companion dog walking intervention compared to an attention control education intervention for ICU survivors?

Participants in the intervention group will be asked to:

* Participate in dog walking with their pet dog at least three times per week, for at least 10 minutes each walk, for 8-weeks.
* Wear an activity monitor and record their dog walks in a diary.
* Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8.
* Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8.

Participants in the control group will be asked to:

* Read educational materials about their pet dog's health once every week (education materials are provided by the researchers).
* Wear an activity monitor and record when they read their education materials in a diary.
* Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8.
* Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8.

Participants will be assigned to an intervention group or a control group to see if there are differences in depression, anxiety, serum cortisol, and quality of life.

Conditions

Interventions

BEHAVIORAL

Companion Dog Walking

Participants will be asked to walk their dog three times per week, for a minimum of 30 minutes each day of walking, over an 8-week period.

BEHAVIORAL

Attention Control Group

Participants will be asked to read educational materials on dog health once per week, over an 8-week period.

Sponsors & Collaborators

  • Sigma Theta Tau International Honor Society of Nursing

    collaborator OTHER
  • University of Missouri, Kansas City

    lead OTHER

Principal Investigators

  • Lindsey Nelson, MSN, RN · University of Missouri, Kansas City

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820308 on ClinicalTrials.gov